LISINOPRIL Drug Patent Profile
✉ Email this page to a colleague
When do Lisinopril patents expire, and what generic alternatives are available?
Lisinopril is a drug marketed by Accord Hlthcare, Ascent Pharms Inc, Aurobindo, Chartwell Rx, Corepharma, Heritage Pharma, Hikma Intl Pharms, Invagen Pharms, Lupin, Prinston Inc, Rising, Sciegen Pharms Inc, Strides Pharma, Sun Pharm Inds Ltd, Teva, Watson Labs, Wockhardt Bio Ag, Epic Pharma Llc, Mylan, and Sandoz. and is included in thirty-two NDAs.
The generic ingredient in LISINOPRIL is hydrochlorothiazide; lisinopril. There are thirty-two drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; lisinopril profile page.
Summary for LISINOPRIL
Recent Clinical Trials for LISINOPRIL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Medical College of Wisconsin | Early Phase 1 |
University of Rochester | Early Phase 1 |
Wake Forest University Health Sciences | Phase 4 |
Pharmacology for LISINOPRIL
Drug Class | Angiotensin Converting Enzyme Inhibitor |
Mechanism of Action | Angiotensin-converting Enzyme Inhibitors |
Medical Subject Heading (MeSH) Categories for LISINOPRIL
Anatomical Therapeutic Chemical (ATC) Classes for LISINOPRIL
Paragraph IV (Patent) Challenges for LISINOPRIL
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
QBRELIS | Oral Solution | lisinopril | 1 mg/mL | 208401 | 1 | 2019-10-24 |
US Patents and Regulatory Information for LISINOPRIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rising | LISINOPRIL | lisinopril | TABLET;ORAL | 075999-006 | Jul 1, 2002 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Watson Labs | LISINOPRIL | lisinopril | TABLET;ORAL | 076059-005 | Jul 1, 2002 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Hikma Intl Pharms | LISINOPRIL | lisinopril | TABLET;ORAL | 076063-006 | Jun 27, 2003 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Heritage Pharma | LISINOPRIL | lisinopril | TABLET;ORAL | 075752-002 | Jul 1, 2002 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |